Enantiomers, or molecule pairs that are mirror images of each other, make up more than half of FDA-approved drugs in use ...

Hold out your hands, palms up, and move them so they are on top of each other. With a little experimentation—and perhaps a ...

Innovation Research Center of Chiral Drugs, Institute for Advanced Study, Chengdu University, Chengdu 610106, China China National Engineering Research Center of Chiral Drugs, Chengdu Institute of ...

The chirality and folding of the helix were crucial in this process, with stretched helices showing slower photodegradation compared to compact ones. This feature is highly desirable for controlled ...

A new federal rule would reclassify marijuana as a less-dangerous, Schedule III drug. It’s a significant shift, even as it does not legalize the drug. By Eileen Sullivan Reporting from ...

Attribution (BY): Credit must be given to the creator. Many drugs are chiral with their chirality determining their biological interactions, safety, and efficacy. Since the 1980s, there has been a ...

Researchers have been actively looking for novel antitubercular medications with little side effects that are effective against drug-resistant strains to solve this problem. The usage of chiral drugs ...

In pharmaceutical research, chirality, or the ability of molecules to exist in two or more mirror-image forms, plays an important function. Numerous drugs are chiral, and their different enantiomers ...

These drugs are called chiral compounds – meaning they exist as two nonsuperimposable mirror images. For example, your hands are also nonsuperimposable mirror images of each other. Although they ...

which is determining if drugs and supplements with chiral structures are turning in the correct direction. Drugs containing molecules with the wrong twist can cause unpleasant or dangerous side ...

Therefore, the stereoisomer distribution of chiral drug products must be characterized and evaluated during the drug discovery and development pipeline. Moreover, various chiral drugs present a ...